Services
ECELLFrance offers to academics and industrials an assistance for the implementation of their preclinical and/or clinical programs in the field of cell-based therapies.
The infrastructure provides services covering the entire MSC-based production and development pipeline :
Mesenchymal Stem Cell (MSC) production
Quality control, potency tests and MSC safety testing
Immunomonitoring of MSC treated patients
NON clinical studies
MSC efficiency in validated disease models :
- Osteoarticular diseases
- Auto-immune diseases
- Cutanueous conditions
- Ischemia
- Stroke and neurological disorders
Regulatory pre-clinical studies :
- Biodistribution
- Pharmacotoxicology
Assistance with regulatory dossier
Investigator brochure, IMPD, CRF
Assistance with Phase I and II clinical trials
Design, methodology, statistics, meeting with the French health authorities (CPP)